Company / FCF Margin
TENAX THERAPEUTICS, INC. FCF Margin History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-5833.8%
FY2016
5-year range
-5833.8% / -414.7%
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -414.7% to -5833.8% over the past 2 years.
Based on SEC 10-K filings.
-5833.8% in FY2016 with a 3-year CAGR of -3553.3%.
Declined from -414.7% to -5833.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -3553.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, fcf margin increased 0.0% year-over-year.
- Peak fcf margin was recorded in FY2014.
- Lowest fcf margin in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | -5833.8% | +0.0% |
| FY2015 | -5833.8% | -1306.8% |
| FY2014 | -414.7% | +81.8% |
| FY2013 | -2280.5% | +72.8% |
| FY2012 | -8378.6% | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026